The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4S)-4-benzyl-3-(2-(bicyclo[2.2.1]heptan-2-yl)ethyl)-1-(4-((S)-2-propyl-4,5-dihydro-1H-imidazol-4-yl)butyl)imidazolidine-2-thione ID: ALA4064439
PubChem CID: 137637386
Max Phase: Preclinical
Molecular Formula: C29H44N4S
Molecular Weight: 480.77
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCC1=N[C@@H](CCCCN2C[C@H](Cc3ccccc3)N(CCC3CC4CCC3C4)C2=S)CN1
Standard InChI: InChI=1S/C29H44N4S/c1-2-8-28-30-20-26(31-28)11-6-7-15-32-21-27(19-22-9-4-3-5-10-22)33(29(32)34)16-14-25-18-23-12-13-24(25)17-23/h3-5,9-10,23-27H,2,6-8,11-21H2,1H3,(H,30,31)/t23?,24?,25?,26-,27-/m0/s1
Standard InChI Key: BHSQXIQZFCCWQV-CTEMSKPWSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
18.3224 -22.7611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1525 -21.9539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3684 -21.6973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1984 -20.8901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4142 -20.6335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1622 -19.8489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3372 -19.8473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0807 -20.6315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7473 -21.1176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7463 -21.9427 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.8535 -19.1790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2531 -18.4568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0750 -18.4460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4744 -17.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0489 -17.0172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2197 -17.0349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8242 -17.7565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2956 -20.8849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6835 -20.3318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1067 -23.0177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3614 -23.7978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1864 -23.7995 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4428 -23.0153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7763 -22.5292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2280 -22.7618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8929 -20.5825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4010 -21.9552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1862 -21.7017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5574 -21.1854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9684 -21.5959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1833 -20.9383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1116 -22.3464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2407 -21.1682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5138 -20.5942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
7 11 1 1
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
8 18 1 0
18 19 1 0
20 1 1 6
20 21 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 20 1 0
23 25 1 0
19 26 1 0
25 27 1 0
27 28 1 0
26 29 1 0
29 30 1 0
26 31 1 0
31 32 1 0
32 30 1 0
30 33 1 0
33 34 1 0
34 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 480.77Molecular Weight (Monoisotopic): 480.3287AlogP: 5.67#Rotatable Bonds: 12Polar Surface Area: 30.87Molecular Species: BASEHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 10.47CX LogP: 5.89CX LogD: 3.56Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.31Np Likeness Score: -0.06
References 1. Nefzi A, Marconi GD, Ortiz MA, Davis JC, Piedrafita FJ.. (2017) Synthesis of dihydroimidazole tethered imidazolinethiones and their activity as novel antagonists of the nuclear retinoic acid receptor-related orphan receptors (RORs)., 27 (7): [PMID:28242276 ] [10.1016/j.bmcl.2017.02.014 ]